- 1Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, VA, United States
- 2Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, United States
- 3Personalized Care Program, Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, United States
- 4Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
- 5Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, United States
- 6Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States
A Correction on
Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by Maggo S, Pan Y, Ostrow D, Nguyen JQ, Biegel JA, Deardorff MA and Gai X (2025). Front. Genet. 16:1574325. doi: 10.3389/fgene.2025.1574325
In the published article, there was an error in Table 1 as published. Table one, included two instances of SLCO1B1 The first instance should be CYP2B6. The corrected Table1 and its caption appear below.

Table 1. Phenotype frequency (%) comparison of the Whole Exome Sequencing cohort (CES) against data published on the PharmGKB (PGKB) website and a recent publication (LIT) (Tremmel et al., 2023). For population comparisons, AMR (Admixed American) from CES was compared against LAT (Latino) from PGKB due to differences in biogeographical classifications. Blank values for, PGKB, or LIT indicate values not available at the time of publication.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: pharmacogenomic (PGx) research, pharmacogenetic testing, bioinformatic analyses, admixed american pharmacogenomics, pharmacogenomics data
Citation: Maggo S, Pan Y, Ostrow D, Nguyen JQ, Biegel JA, Deardorff MA and Gai X (2025) Correction: Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing. Front. Genet. 16:1639666. doi: 10.3389/fgene.2025.1639666
Received: 02 June 2025; Accepted: 25 June 2025;
Published: 08 July 2025.
Edited and reviewed by:
José A. G. Agúndez, University of Extremadura, SpainCopyright © 2025 Maggo, Pan, Ostrow, Nguyen, Biegel, Deardorff and Gai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Simran Maggo, c2ltcmFuLm1hZ2dvQHN1LmVkdQ==; Xiaowu Gai, eGdhaUBtY3cuZWR1